|
業務類別
|
Biotechnology |
|
業務概覽
|
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape. |
| 公司地址
| 1601 Trapelo Road, Suite 178, Waltham, MA, USA, 02451 |
| 電話號碼
| +1 781 819-0080 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.invivyd.com |
| 員工數量
| 100 |
| Mr. William Duke, M.B.A. |
Principal Executive Officer, Chief Financial Officer and Principal Accounting Officer |
-- |
05/03/2026 |
| Mr. Robert Allen, PhD |
Chief Scientific Officer |
-- |
07/04/2025 |
| Ms. Julie Green, M.B.A. |
Chief Human Resources Officer and Head of Communications |
美元 398.90K |
07/04/2025 |
| Mr. Timothy Lee |
Chief Commercial Officer |
美元 240.42K |
07/04/2025 |
| Ms. Jill Andersen, J.D. |
Chief Legal Officer and Corporate Secretary |
-- |
07/04/2025 |
|
|
| Mr. Kevin F. Mclaughlin |
Independent Director |
05/03/2026 |
| Mr. Ajay Royan |
Director |
05/03/2026 |
| Mr. Marc Elia |
Chairman of the Board |
05/03/2026 |
| Dr. Paul B. Bolno, M.B.A.,M.D. |
Director |
05/03/2026 |
| Ms. Tamsin Berry |
Independent Director |
05/03/2026 |
| Mr. Terrance G. Mcguire |
Independent Director |
05/03/2026 |
|
|
|
|
